Literature DB >> 16393268

Mycobacterium tuberculosis infection may protect against allergy in a tuberculosis endemic area.

C C Obihara1, J L L Kimpen, R P Gie, S W Lill, M O Hoekstra, B J Marais, H S Schaaf, K Lawrence, P C Potter, E D Bateman, C J Lombard, N Beyers.   

Abstract

BACKGROUND: Epidemiological studies have shown an inverse relation of mycobacterial infection and the frequency of allergic diseases and asthma. Recent evidence suggests that allergic inflammation may be inhibited in the presence of chronic and persistent infections, such as that by Mycobacterium tuberculosis (MTB). The relation of tuberculin skin test (TST) size, an accepted marker of MTB infection and the frequency of allergic disease symptoms has not been reported from an area where MTB infection is endemic.
OBJECTIVE: To investigate the association of TST and allergic disease symptoms, in children living in a tuberculosis (TB) endemic area.
METHODS: In this cross-sectional study, 841 children aged 6-14 years from randomly selected household addresses in two poor communities of Cape Town, South Africa, were investigated with TST and standardized International Study on Asthma and Allergies in Childhood-based questionnaire on allergic disease symptoms.
RESULTS: Children with positive TST (> or =10 mm) were significantly less likely to have allergic disease symptoms, in particular allergic rhinitis (AR) (adjusted odds ratio 0.43; 95% confidence interval 0.24-0.79) than those with negative TST. This association remained significant after adjusting for possible confounders and correcting for the effect of clustering (>1 child per household address) in the sample. There was a significant inverse linear trend in the relation of TST size in millimetre and the frequency of allergic disease symptoms, in particular AR (P<0.001).
CONCLUSIONS: These results of inverse association of strong TST reaction and allergic disease symptoms in children from a TB endemic area are in support of the hypotheses that allergic inflammation may be inhibited by chronic infections, such as MTB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16393268     DOI: 10.1111/j.1365-2222.2005.02408.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  6 in total

Review 1.  The potential of Mycobacterium to protect against allergy and asthma.

Authors:  Charles C Obihara; Jan L L Kimpen; Nulda Beyers
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

2.  A child with lumps and bumps down on the farm.

Authors:  Manal Alsaif; Joan L Robinson; Gordon Lees; Timothy K Vander Leek
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-05       Impact factor: 2.471

3.  Asthma, Sinonasal Disease, and the Risk of Active Tuberculosis.

Authors:  Anthony C Yii; Avril Z Soh; Cynthia B E Chee; Yee T Wang; Jian-Min Yuan; Woon-Puay Koh
Journal:  J Allergy Clin Immunol Pract       Date:  2018-08-18

4.  Risk factors for asthma among schoolchildren who participated in a case-control study in urban Uganda.

Authors:  Harriet Mpairwe; Milly Namutebi; Gyaviira Nkurunungi; Pius Tumwesige; Irene Nambuya; Mike Mukasa; Caroline Onen; Marble Nnaluwooza; Barbara Apule; Tonny Katongole; Gloria Oduru; Joseph Kahwa; Emily L Webb; Lawrence Lubyayi; Neil Pearce; Alison M Elliott
Journal:  Elife       Date:  2019-11-15       Impact factor: 8.140

5.  Allergic Asthma Favors Brucella Growth in the Lungs of Infected Mice.

Authors:  Arnaud Machelart; Georges Potemberg; Laurye Van Maele; Aurore Demars; Maxime Lagneaux; Carl De Trez; Catherine Sabatel; Fabrice Bureau; Sofie De Prins; Pauline Percier; Olivier Denis; Fabienne Jurion; Marta Romano; Jean-Marie Vanderwinden; Jean-Jacques Letesson; Eric Muraille
Journal:  Front Immunol       Date:  2018-08-10       Impact factor: 7.561

6.  Risk factors associated with rhinitis, allergic conjunctivitis and eczema among schoolchildren in Uganda.

Authors:  Harriet Mpairwe; Gyaviira Nkurunungi; Pius Tumwesige; Hellen Akurut; Milly Namutebi; Irene Nambuya; Marble Nnaluwooza; Barbara Apule; Caroline Onen; Tonny Katongole; Emmanuel Niwagaba; Mike Mukasa; Emily L Webb; Alison M Elliott; Neil Pearce
Journal:  Clin Exp Allergy       Date:  2020-11-08       Impact factor: 5.018

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.